SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 190.39-2.9%10:22 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Russian Bear who wrote (20499)5/11/1998 8:45:00 PM
From: squetch  Read Replies (1) of 32384
 
RB,What I find funny is that SRGN looks to me like LGND in miniature. Lots of targets and not enough money to develop them. SRGN has 6 target molecules where each molecule might have multiple indications.

Another thing I find funny is LGND is spending 30+million to be profitable in 99. So they think cash and dilution will be less than revenue obviously. They might want it for the other indications, but it is CTCL that they expect to generate the revs. Unless they license the other indications out I guess.
squetch
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext